These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2144 related items for PubMed ID: 19476419

  • 1. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 2. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 3. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG.
    Essent Psychopharmacol; 2005 Jun; 6(5):262-76. PubMed ID: 16222911
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 6. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
    Prescrire Int; 2010 Feb; 19(105):5-8. PubMed ID: 20455329
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA, Bosch-Munsó R, Castells-Cervelló X, Nogueira-Morais M, García-Gimenez E, Casas-Brugué M.
    Rev Neurol; 2010 Feb; 42(10):600-6. PubMed ID: 16703528
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV, Glatt SJ.
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [Abstract] [Full Text] [Related]

  • 12. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Apr; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 13. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR.
    Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
    [Abstract] [Full Text] [Related]

  • 14. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H.
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract] [Full Text] [Related]

  • 15. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [Abstract] [Full Text] [Related]

  • 16. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 17. Review of medication adherence in children and adults with ADHD.
    Adler LD, Nierenberg AA.
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [Abstract] [Full Text] [Related]

  • 18. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ, Cheetham SC, Smith SL.
    Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
    [Abstract] [Full Text] [Related]

  • 19. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP.
    J Clin Psychiatry; 2007 Dec; 68 Suppl 11():23-30. PubMed ID: 18307378
    [Abstract] [Full Text] [Related]

  • 20. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 108.